Analyzing Sysmex (OTCMKTS:SSMXY) & Hyperfine (NASDAQ:HYPR)

Sysmex (OTCMKTS:SSMXY) and Hyperfine (NASDAQ:HYPR) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, dividends and profitability.

Insider & Institutional Ownership

15.0% of Hyperfine shares are held by institutional investors. 26.3% of Hyperfine shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Sysmex and Hyperfine’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sysmex	7.62%	8.01%	5.61%
Hyperfine	-210.75%	-97.88%	-61.81%

Analyst Ratings

This is a breakdown of recent ratings and target prices for Sysmex and Hyperfine, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sysmex	0	2	0	0	2.00
Hyperfine	1	1	3	1	2.67

Hyperfine has a consensus target price of $2.02, suggesting a potential upside of 195.62%. Given Hyperfine’s stronger consensus rating and higher probable upside, analysts plainly believe Hyperfine is more favorable than Sysmex.

Volatility and Risk

Sysmex has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, Hyperfine has a beta of 1.49, indicating that its share price is 49% more volatile than the S&P 500.

Earnings and Valuation

This table compares Sysmex and Hyperfine”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sysmex	$3.32 billion	2.44	$234.01 million	$0.42	31.69
Hyperfine	$11.40 million	6.37	-$35.57 million	($0.38)	-1.80

Sysmex has higher revenue and earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Sysmex, indicating that it is currently the more affordable of the two stocks.

Summary

Hyperfine beats Sysmex on 8 of the 15 factors compared between the two stocks.

About Sysmex

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic testing instruments, reagents and related services. Its products are used by hospitals, clinical laboratories and other healthcare providers to analyze patient samples and support medical diagnosis. The company is best known for its hematology testing systems and also offers products for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory information systems and support services.

About Hyperfine

Hyperfine, Inc. (NASDAQ: HYPR) is a medical technology company focused on making magnetic resonance imaging more accessible and convenient. The company develops portable, low-field MRI technology designed to bring brain imaging directly to patients in locations such as intensive care units, emergency departments, operating rooms and other point-of-care settings. Hyperfine’s primary product is the Swoop Portable MR Imaging System, a compact MRI platform that can be moved to a patient’s bedside. The system is designed to produce brain images without requiring patients to be transported to a traditional radiology department.